Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 1475Neoplasms 996Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 682Stomach Neoplasms 646Lung Neoplasms 583Prostatic Neoplasms 543Pancreatic Neoplasms 457Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 289Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 276Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 240Multiple Myeloma 232Brain Neoplasms 203Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 191Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 140

Interventions

camrelizumab 1Radiotherapy 1Paclitaxel 1Injections 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Chemotherapy × Clear all
NCT05821452 2023-04-20

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Fujian Medical University Union Hospital

Phase 2 Unknown
40 enrolled

Chemotherapy

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Unknown
30 enrolled

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡